A pharmaceutical waste strategy has to address both the routine, low-hazard fraction (expired stock) and the higher-hazard fraction (cytotoxic drugs, controlled substances) with different rigour, since treating everything at the highest hazard level is unaffordable and treating everything at the lowest level is unsafe.
Management steps:
Inventory management — track expiry dates and order quantities to minimize the volume of pharmaceuticals that expire unused in the first place.
Source segregation by hazard class — separate non-hazardous expired stock from cytotoxic/chemotherapy agents and from controlled substances, each of which has a distinct legal disposal requirement.
Reverse distribution — return unexpired, unopened stock to the manufacturer or a licensed reverse-distributor rather than disposing of it.
Take-back programs — use pharmacy or municipal take-back programs for public-generated pharmaceutical waste, keeping it out of household garbage and the sewer.
Never discharge to the sanitary sewer or flush — pharmaceuticals are increasingly implicated in aquatic endocrine disruption and antimicrobial resistance, so drain disposal is avoided even though it was historically common practice.
Engage a licensed hazardous-waste hauler for final treatment/disposal and maintain manifests for regulatory accountability.
Treatment options:
High-temperature incineration — the preferred method for cytotoxic/chemotherapy waste and most controlled substances, since combustion destroys the active pharmaceutical ingredient completely and prevents diversion.
Alkaline (chemical) hydrolysis — used for specific reactive or hydrolysable compounds where incineration capacity is unavailable, converting the drug to non-active breakdown products before disposal.
Encapsulation and secure landfill disposal — acceptable only for confirmed non-hazardous expired product where incineration is not accessible, encapsulating the waste in an inert matrix to prevent leaching and diversion.
